Preprint

Article

Progression-Free Survival and Treatment-Free Interval in Head and Neck Cancer With Long-Term Response to Nivolumab: Timing of Active Discontinuation

This version is not peer-reviewed.

This version is not peer-reviewed.

Downloads

148

Views

63

Comments

0

Preprints.org is a free preprint server supported by MDPI in Basel, Switzerland.

MDPI Initiatives

Important Links

Subscribe

Choose an area of interest and we will send you notifications of new preprints at your preferred frequency.

© 2025 MDPI (Basel, Switzerland) unless otherwise stated

Disclaimer

© 2025 MDPI (Basel, Switzerland) unless otherwise stated